CAMBRIDGE NUTRITIONAL SCIENCES PLC Logo

CAMBRIDGE NUTRITIONAL SCIENCES PLC

Develops and manufactures diagnostic tests for food sensitivity and gut health.

CNSL | IL

Overview

Corporate Details

ISIN(s):
GB00B1CS9459 (+1 more)
LEI:
2138007U9P4BTZTYIR92
Country:
United Kingdom
Address:
EDEN RESEARCH PARK, CB6 1SE LITTLEPORT

Description

Cambridge Nutritional Sciences PLC is a medical diagnostics company that develops, manufactures, and distributes products focused on promoting a personalised approach to health. The company specialises in a range of tests associated with food sensitivity and gut health. Utilising advanced diagnostic technology, its products are designed for use by healthcare professionals and their patients to identify potential food reactions and guide lifestyle and dietary changes. The company's goal is to enable individuals to improve their long-term health and wellbeing by understanding how their diet may be contributing to various health issues.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-19 08:25
Director/PDMR Shareholding
English 39.5 KB
2025-11-10 08:20
Half-year Report
English 252.2 KB
2025-11-04 08:25
Notice of Results & Investor Presentation
English 13.6 KB
2025-09-25 17:30
Result of AGM
English 9.2 KB
2025-08-28 08:00
Notice of AGM & Annual Report
English 9.3 KB
2025-08-21 08:00
Grant of Options
English 17.1 KB
2025-08-19 08:00
Final Results
English 941.0 KB
2025-07-31 08:00
Notice of Results & Investor Presentation
English 13.8 KB
2025-07-10 08:00
Directorate Change
English 18.8 KB
2025-07-02 08:00
Holding(s) in Company
English 22.2 KB
2025-05-27 08:00
Trading Update
English 14.1 KB
2025-05-23 08:00
Resolution on HSE Matter
English 13.5 KB
2025-03-19 08:00
Omega Diagnostics Summons Update
English 12.1 KB
2025-03-18 15:48
Holding(s) in Company
English 21.9 KB
2025-02-06 08:00
Director/PDMR Shareholding
English 30.7 KB

Automate Your Workflow. Get a real-time feed of all CAMBRIDGE NUTRITIONAL SCIENCES PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CAMBRIDGE NUTRITIONAL SCIENCES PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CAMBRIDGE NUTRITIONAL SCIENCES PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.